The population of HIV/Aids-ravaged southern Africa is expected to decline by 22% by 2050, according to a recent study. The latest world population data sheet of the United States-based Population Reference Bureau estimates South Africa's population will drop from 44 million this year to 35.1 million in 2025, and to 32.5 million in 2050 - a 26% decline.
Equity in Health
The population of HIV/Aids-ravaged southern Africa is expected to decline by 22% by 2050, according to a recent study. The latest world population data sheet of the United States-based Population Reference Bureau estimates South Africa's population will drop from 44 million this year to 35.1 million in 2025, and to 32.5 million in 2050 - a 26% decline.
'Avoid Aids, come inside' says the sign outside the sex shop near the Durban beachfront. Just 100 meters away 500 Treatment Action Campaign (TAC) activists, from 110 branches across South Africa, were meeting at the second TAC National Congress to plan how to carry on their fight for the roll out of a comprehensive treatment plan for the 5 million people living with HIV-AIDS. With the highest national HIV prevalence in the world, AIDS is estimated to have caused 40% of all adult deaths in 2001, as many as 1,000 people a day according to UNAIDS (a figure not challenged by the ANC government). Addressing the Congress on the final day, the historic nature of this campaign was underscored by the UN Special Envoy for HIV/AIDS, Stephen Lewis, who compared TAC with some of the greatest social movements of the twentieth century and the "anti-globalisation" movement of the twenty-first.
Scientists and activists at South Africa's first national AIDS conference, which drew to a close on August 6, urged the government to roll out rapid drug treatment for millions of South Africans dying from the disease. "The message is: don't wait. You've got to do something, and you have got to do it now," Salim Abdool Karim, scientific chair of the conference, told Reuters. "This is not an attack on the government. This is scientific fact." The four-day conference was a watershed in South Africa's public debate on AIDS policy, which is dominated by angry efforts to persuade the government to launch a national treatment program with antiretroviral drugs, which many scientists say represent the only way to avoid catastrophe.
The World Health Organisation announced last month that it will create a new model to buy antiretroviral AIDS drugs in hopes of dramatically speeding distribution and reducing the cost of the life-saving medication. The plan comes from collaboration among tuberculosis experts, foremost among them the new WHO director general, Jong-wook Lee. That program, called the TB Drug Facility, purchases drugs in bulk on behalf of countries and then oversees the distribution.
Read a response to this article in the Letters section of Equinet News.
The Zambian government has instituted criteria to determine which of the country's 200,000 HIV/AIDS patients will have access to free antiretroviral drug treatment, Xinhua News Agency reports. Under the new guidelines, HIV-positive people wishing to access the drugs must undergo voluntary HIV testing and counselling as well as a clinical test to determine their viral load.
Figures released by the government last week showing a drop in the number of Zimbabweans infected by HIV/AIDS were only a correction of flawed estimates from previous surveys and did not mean the prevalence of the disease was declining in the country, HIV/AIDS experts said.
The quest for drugs to fight the world's most neglected tropical infectious diseases gained fresh momentum with the formal launch of the "drugs for neglected diseases" initiative this week. Médecins Sans Frontières has teamed up with five international public organisations to promote affordable and effective drugs against leishmaniasis, human African trypanosomiasis, and Chagas' disease, among other infections that affect millions of people across Asia, Africa, and Latin America.
Aids activists are angry about the government's indecision over providing anti-Aids drugs and look set to resume their civil disobedience campaign. A final decision about returning to civil disobedience could be made at the Treatment Action Campaign's (TAC) national congress, which is to be held in Durban within the next two weeks. Provincial meetings ahead of the congress have already voted overwhelmingly in favour of a return to the disobedience campaign, which was suspended in April after a meeting between TAC representatives and Deputy President Jacob Zuma.
Gaps in child mortality between rich and poor countries are unacceptably wide and in some areas are becoming wider, as are the gaps between wealthy and poor children within most countries. Poor children are more likely than their better-off peers to be exposed to health risks, and they have less resistance to disease because of undernutrition and other hazards typical in poor communities. Regular monitoring of inequities and use of the resulting information for education, advocacy, and increased accountability among the general public and decision makers is urgently needed, but will not be sufficient. Equity must be a priority in the design of child survival interventions and delivery strategies, and mechanisms to ensure accountability at national and international levels must be developed.